Product Images Valsartan And Hydrochlorothiazide
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 11 images provide visual information about the product associated with Valsartan And Hydrochlorothiazide NDC 0781-5951 by Sandoz Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This appears to be a table/chart showing blood pressure readings and medication dosages. The table/chart includes readings for baseline SBP (systolic blood pressure) in mmHg and medications Valsartan and Hydrochlorothiazide in varying dosages. The top line mentions SBP<140 (mmHg), indicating that the chart is possibly showing the effectiveness of medication in reducing blood pressure below 140 mmHg.*
The text describes a medication called Valsartan and Hydrochlorothiazide Tablets. The manufacturer of the medication appears to be Sandoz.*
This is a medication called Valsartan and Hydrochlorothiazide Tablets. Each tablet contains 320mg of Valsartan and 25mg of Hydrochlorothiazide. The brand name is Beonly and this package contains 90 tablets.*
This appears to be a chart showing blood pressure measurements in mmHg (millimeters of mercury) with a focus on DBP (diastolic blood pressure) levels below 90. The chart shows varying measurements at different times with the help of medication and includes Valsartan and Hydrochlorathiazide tablets in dosage ranging from 160-320mg. The final line indicates a baseline measurement. There is some random text that is not understandable.*
This is a description of a graph displaying blood pressure readings. The text indicates that the graph is measuring SBP (systolic blood pressure) in mmHg (millimeters of mercury). The graph compares the effectiveness of two medications, Vaisartan and Rydrochlorothiazide (in a 320/25 mg dose) and Vaisartan alone (in a 320 mg dose) with a placebo. The graph shows the change in SBP over time, starting at baseline SBP, and reaching up to 180 mmHg. The text suggests that this graph is part of a study evaluating the efficacy of these medications in lowering blood pressure.*
This appears to be a chart showing blood pressure values, with baseline DBP in mmHg on the X-axis and % DBP<80 on the Y-axis. The chart represents measurements for different medications and doses, including Valsartan and Hydrochlorothiazide. The text seems to be incomplete and difficult to interpret without additional context.*
This is the information about a medication called Valsartan and Hydrochlorothiazide Tablets, USP, manufactured by a company called Sandoz. No further information about the medication or its uses is provided.*
Valsartan and Hydrochlorothiazide Tablets, USP is a medication manufactured by Sandoz for the treatment of hypertension.*
This is a medication called "Valsartan and Hydrochlorothiazide Tablets, USP". Each tablet contains 160mg of Valsartan and 25mg of Hydrochlorothiazide. The package contains 90 tablets.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.